iain phillips

[BTOG @BTOGORG]

BTOG is thrilled to see that national implementation of CT screening '…to the high risk group of people aged 55 to 74 years with a history of smoking' is now recommended. With thanks to everyone involved. https://t.co/SZcgbXxhA5 #lungcancerscreening

[Gerry Hanna @gerryhanna]

Delighted to hear that the UK National Screening Committee has recommend implementation of CT screening to the high risk group of people aged 55 to 74 years with a history of smoking.

Hopefully this will save 1000s of lives from lung cancer
https://t.co/HWKEetCqQL

[Crispin Hiley @crispinhiley]

We are very excited about this study and grateful to the grant funder @asthmalunguk and @Mesouk who will fund patient travel. Lots to do before the study opens in Q3 2023 but this is good news for patients with mesothelioma!! @uclcancer @CRUKLungCentre @uclh @TheChristieNHS #lcsm

[Frontiers - Nutrition @FrontNutrition]

New Research: Hypoalbuminaemia as a Prognostic Biomarker of First-Line Treatment Resistance in Metastatic Non-small Cell Lung Cancer: Introduction: Despite significant advances in systemic anticancer therapy (SACT) for non-small cell lung… https://t.co/UKXA8BIfRs #Nutrition

[iain phillips @iphillips_onc]

New review on strategies to reduce the impact of cancer cachexia on patients with lung cancer.

https://t.co/7iZXoFLW6C

@Caleycachexia @laird_barry @RichSkipworth

[Dr Kamal Thippu MD FRCR @KamalThippu]

#WeekendScienceWith @ClinOncology 📢Special issue on hypofractionation! Expertly curated articles by the leaders in the field, including @SABRconsortium normal tissue dose guidelines @tvajithkumar @achoud72 #radonc #sabr ➡️https://t.co/gUT3prOYrx

[iain phillips @iphillips_onc]

Increasing systemic inflammation, assessed using a novel scoring system, leads to a poorer outcome in patients receiving first line immunotherapy for non-small cell lung cancer. @laird_barry @Caleycachexia

https://t.co/1XH2CHEqvL

[iain phillips @iphillips_onc]

Response to recent editorials in clinical oncology regarding Stereotactic radiotherapy for use in oligometastatic disease. @sjharrow @drolsononcology @drdavidpalma DOI:https://t.co/V3BHtHsLv2

[BTOG @BTOGORG]

. @drMaryOBr has been awarded the BTOG 2022 Lifetime Achievement Award #BTOG22

[Caledonian Cachexia Collaborative @Caleycachexia]

Early dietitian referral in lung cancer: use of machine learning | BMJ Supportive & Palliative Care by ⁦@Caleycachexia⁩ Iain Phillips and ⁦@LindseyAllan6⁩ https://t.co/lLZnVSm5ke